Original language | English |
---|---|
Pages (from-to) | S11-S11 |
Number of pages | 1 |
Journal | European Journal of Cancer |
Volume | 138 |
DOIs | |
Publication status | Published - Oct 2020 |
Event | 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Duration: 24 Oct 2020 → 25 Oct 2020 |
Preliminary results from an open-label, multicenter phase 1/2 dose escalation and expansion study of THOR-707, a novel not-Alpha IL-2, as a single agent in adult subjects with advanced or metastatic solid tumors
F. Janku, R. Abdul-Karim, A. Azad, J. Bendell, H. Gan, S. Sen, T. Tan, J. Wang, N. Marina, L. Baker, L. Ma, J. Mooney, D. Luo, J. Leveque, M. Milla, Tarek Meniawy
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
1
Citation
(Web of Science)